ITACA NSCLC study: Final results
ITACA NSCLC study: Final results
KEYNOTE-598: pembrolizumab with ipilimumab or placebo in patients with untreated metastatic NSCLC
Latest in EGFR-positive NSCLC with exon 20 insertion mutations
WCLC 2020 overview
WCLC 2020: Updates from the CHRYSALIS trial and what it means for patients with NSCLC
New data from rare EGFR alterations in NSCLC from WCLC 2020